Ant Group Achieves Carbon Neutrality in Its Own Operations With Green Computing Technologies Driving Indirect Emission Cuts
19.4.2022 16:31:00 EEST | Business Wire | Press release
Ant Group today announced it has achieved carbon neutrality in its own operations (Scopes 1 & 2), according to 2021 emission figures certified by the China Environmental United Certification Center (CEC). This marks the Company’s first major step towards fulfilling the commitments it made in March 2021 to achieve net zero in carbon emissions by 2030, including providing periodic updates on its progress towards achieving this important goal.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220419005649/en/
Ant Group achieved Scopes 1 & 2 carbon neutrality in its own operations in 2021 (Graphic: Business Wire)
According to CEC certified figures, in 2021, Ant Group reduced a total of 37,909.87 tons of CO2e, equivalent to taking 15,000 cars off the road each year, assuming each car is driven 12,000 kilometers per year at 0.203 kilogram of CO2e per kilometer.
To validate its results, the CEC used Carbon Matrix, AntChain’s software-as-a-service (SaaS) product that helps businesses and institutions track and certify corporate carbon emissions on blockchain. The CEC was an official service provider to the 2022 Winter Olympics, measuring the Olympic Committee’s carbon reduction effectiveness.
In 2021, Ant Group achieved carbon neutrality in its own operations (Scopes 1 & 2) through a combination of reductions, substitutions and offsets:
- Reduction: reduced 1,668.60 tons of CO2e by improving its energy savings and efficiency practices.
- Substitution: avoided 21,883.63 tons of CO2e through the use of renewable energy.
- Offset: offset 23,159.54 tons of CO2e through the purchase of China Certified Emission Reductions (CCERs).
“This is a major milestone since we announced our carbon neutrality goal on March 12, 2021,” said Yijie Peng, Vice President of Ant Group. “Leveraging innovative technologies such as blockchain and green computation, we are well underway to achieve an inclusive, green and sustainable future.”
According to Ant Group’s carbon neutrality roadmap, by 2030, the Company will achieve net zero carbon emissions across Scopes 1, 2 and 3. Scope 1 refers to direct emissions as a result of fossil fuel burning from sources Ant Group owns or controls. Scope 2 refers to indirect emissions associated with the purchase of electricity and the use of heating or cooling networks. Scope 3 refers to all other carbon emissions generated along Ant Group’s value chain, such as the use of data centers, business travel and daily commute programs provided by the Company.
In 2021, Ant Group reduced a total of 36,241.27 tons of CO2e in Scope 3, of which the adoption of green computing technologies contributed to 29,591.48 tons – or about 82% of all the Scope 3 reduction.
Data centers, which are at the core of today’s digital economy, consume a large amount of electricity and generate considerable carbon emissions. Following the adoption of green computing technologies in 2019 – such as online-offline hybrid deployment, cloud-native time-shared scheduling, AI-based auto scaling and OceanBase enterprise-level distributed relational database – Ant Group more than doubled the utilization rates of data servers in three years, while meaningfully reducing its carbon footprint.
Ant Group’s remaining Scope 3 carbon emission reductions came from sourcing environmentally friendly office supplies, and encouraging employees to take public transportation or shared rides – including taxis and carpooling for local business travel.
The CEC’s carbon neutrality certificate for Ant Group (in Chinese language only) is publicly available on the Information Platform for Carbon Neutrality, which is affiliated with the Environmental Development Center of China’s Ministry of Ecology and Environment.
About Ant Group
Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220419005649/en/
Contact information
Media Enquiries
Le SHEN
Shenle.sl@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom